Vaccines, human use300220 (Harmonized System 1992 for 6-digit)
2021 World Trade: $115B, Rnk 16 / 4641
2021 Top Exporter | Top Importer: $36B | $13.5B, Belgium | Belgium
2021 Product Complexity: 1.37, Rnk 297 / 4648
2020 - 2021 Export Growth (CAGR): 253%, Rnk 6 / 4641
2018 Mean Tariff: 0.86%, Rnk 6418 / 6538
2021 Share of World Trade: 0.55%, Rnk 16 / 4641
Overview This page contains the latest trade data of Vaccines, human use. In 2021, Vaccines, human use were the world's 16th most traded product, with a total trade of $115B. Between 2020 and 2021 the exports of Vaccines, human use grew by 253%, from $32.7B to $115B. Trade in Vaccines, human use represent 0.55% of total world trade.
Vaccines, human use are a part of Vaccines, blood, antisera, toxins and cultures.
Exports In 2021 the top exporters of Vaccines, human use were Belgium ($36B), China ($15.4B), United States ($14.2B), Germany ($11.8B), and Spain ($6.79B).
Imports In 2021 the top importers of Vaccines, human use were Belgium ($13.5B), Germany ($10.3B), United States ($8.58B), Spain ($7.24B), and Japan ($5.55B).
Tariffs In 2018 the average tariff for Vaccines, human use was 0.86%, making it the 6418th lowest tariff using the HS6 product classification.
Ranking Vaccines, human use ranks 297th in the Product Complexity Index (PCI).
Description A vaccine is a substance that creates immunity against a disease. It is typically administered by injection, but may be administered orally or by aerosol. Vaccines can protect against many infectious diseases including measles, mumps, tetanus, polio, rubella, and hepatitis A.
The following visualization shows the latest trends on Vaccines, human use. Countries are shown based on data availability.
For a full breakdown of trade patterns, visit the trend explorer or the product in country profile.
* Using January 2020 exchange rates when trade data is reported in local currency.
Trade By Country
Vaccines, human use are the world's 16th most traded product.
In 2021, the top exporters of Vaccines, human use were Belgium ($36B), China ($15.4B), United States ($14.2B), Germany ($11.8B), and Spain ($6.79B).
In 2021, the top importers of Vaccines, human use were Belgium ($13.5B), Germany ($10.3B), United States ($8.58B), Spain ($7.24B), and Japan ($5.55B).
Trade by country
Top Origin Growth (2020 - 2021): Belgium, $24.5B
Top Destination Growth (2020 - 2021): Germany, $8.66B
Between 2020 and 2021, the exports of Vaccines, human use grew the fastest in Belgium ($24.5B), China ($15.1B), United States ($12.1B), Germany ($11.2B), and Spain ($6.49B).
Between 2020 and 2021, the fastest growing importers of Vaccines, human use were Germany ($8.66B), Spain ($6.48B), Belgium ($5.93B), Japan ($5.19B), and Brazil ($3.39B).
Cumulative market share
This chart shows the evolution of the market concentration of exports of Vaccines, human use.
In 2021, market concentration measured using Shannon Entropy, was 3.32. This means that most of the exports of Vaccines, human use are explained by 10 countries.
This map shows which countries export or import more of Vaccines, human use. Each country is colored based on the difference in exports and imports of Vaccines, human use during 2021.
In 2021, the countries that had a largest trade value in exports than in imports of Vaccines, human use were Belgium ($22.4B), China ($13.9B), Ireland ($6.15B), Switzerland ($5.81B), and United States ($5.57B).
In 2021, the countries that had a largest trade value in imports than in exports of Vaccines, human use were Japan ($5.34B), Brazil ($4.08B), United Kingdom ($3.13B), Indonesia ($2.99B), and Pakistan ($2.91B).
This visualization shows the countries that have an important ratio of their trade related to Vaccines, human use. It is possible to select the main countries that export or import Vaccines, human use in the world, or by continent, as well as select the measure of interest.
The Complexity-Relatedness diagram compares the risk and the strategic value of a product's potential export opportunities. Relatedness is predictive of the probability that a country increases its exports in a product. Complexity, is associated with higher levels of income, economic growth potential, lower income inequality, and lower emissions.
Have questions, comments, or concerns?
Send us an e-mail: [email protected]
v5.1.15 owl